MedTrace Logo

CLARYS: CLinical Assessment of WEB® Device in Ruptured aneurYSms

NCT02687607 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2023-01-26

No results posted yet for this study

Summary

An observational non-randomized, multi-center, prospective assessment of the clinical utility of the WEB Aneurysm Embolization System in subjects with ruptured intracranial aneurysms deemed appropriate for endovascular treatment. The population being treated in this Registry is a subset of the CE marked indication.

Conditions

  • Brain Aneurysm

Interventions

DEVICE

WEB Aneurysm Embolization System

Sponsors & Collaborators

  • Microvention-Terumo, Inc.

    lead INDUSTRY

Principal Investigators

  • Laurent Spelle, MD, PhD · CHU Bicetre

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-10-10
Completion
2018-12-04

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02687607 on ClinicalTrials.gov